| Hodge, Theo |
EBONI, NCT05514509: A Study Evaluating Implementation Strategies for the Delivery of APRETUDE for Black cis-and Transgender Women in United States EHE Territories |
|
|
| Recruiting | 4 | 250 | US | APRETUDE, Cabotegravir tablet | ViiV Healthcare | HIV Infections | 09/25 | 09/25 | | |
PROMISE-US, NCT05388474: A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab |
|
|
| Recruiting | N/A | 600 | US | No ibalizumab or Pre-ibalizumab treatment, Ibalizumab, On ibalizumab treatment | Theratechnologies, Excelsus Statistics Inc., Health Psychology Research Group (HPR), ICON Clinical Research | HIV Infections, Multi-Antiviral Resistance | 06/25 | 12/25 | | |
| Bordon, Jose |
| Recruiting | N/A | 753 | US | PositiveLinks | George Washington University, National Institute of Mental Health (NIMH), University of Virginia | HIV/AIDS | 04/25 | 06/25 | | |
DC Cohort, NCT01206920: Development of a City-Wide Cohort of HIV-Infected Persons in Care in the District of Columbia: the |
|
|
| Recruiting | N/A | 15000 | US | | George Washington University, National Institute of Allergy and Infectious Diseases (NIAID) | HIV, AIDS | 01/41 | 01/41 | | |
| Monson, Erich |
NCT04561258: Study to Evaluate the Safety of a Gene and Cell Therapy Product in Participants With HIV That is Well-Controlled on Antiretroviral Therapy |
|
|
| Completed | 1 | 7 | US | AGT103-T | American Gene Technologies International Inc. | HIV | 08/22 | 11/22 | | |
| Sawney, Shari |
PROMISE-US, NCT05388474: A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab |
|
|
| Recruiting | N/A | 600 | US | No ibalizumab or Pre-ibalizumab treatment, Ibalizumab, On ibalizumab treatment | Theratechnologies, Excelsus Statistics Inc., Health Psychology Research Group (HPR), ICON Clinical Research | HIV Infections, Multi-Antiviral Resistance | 06/25 | 12/25 | | |
